• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Stock

US FDA greenlights first glucose monitoring system for weight loss

by August 20, 2025
by August 20, 2025

In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval of the first-ever glucose monitoring system designed specifically for weight loss, developed by the startup Signos. 

This approval introduces a new tool for Americans seeking to manage their weight.

Current weight loss treatments, such as popular GLP-1 drugs and surgical procedures, are generally restricted to patients who are obese or have a specific BMI, according to a CNBC report.

Access to obesity medications like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound is challenging because of their high price, inadequate US insurance coverage, and limited availability.

Accessibility

However, Signos now offers a membership for patients to access its system, which combines an AI platform with a Dexcom continuous glucose monitor (CGM), according to the report. 

This system provides personalised, real-time data and lifestyle recommendations to assist with weight management.

“There is now a solution that everybody can use to help on the weight loss journey, and you don’t have to be a certain number of pounds to use it. It’s available for the average American who needs it,” Sharam Fouladgar-Mercer, Signos’ co-founder and CEO, told CNBC in an interview.

The average person might have five pounds to lose, or others might have 100 pounds to lose. We are here to help them at any point in that journey.

Obesity presents a significant challenge to the US healthcare system, incurring costs exceeding $170 billion annually, as reported by the Centers for Disease Control and Prevention. 

Membership process

Government data indicates that nearly 74% of Americans are either overweight or obese. Signos aims to substantially impact this trend, contributing to improved health for many.

Signos offers customers two membership options: a three-month plan for $139 and a six-month plan for $129. 

Upon plan selection, Signos dispatches the necessary Continuous Glucose Monitors (CGMs) to cover the chosen membership duration.

Currently, weight management systems like Signos are not covered by insurers. 

However, their cost is significantly lower than the approximate $1,000 monthly price of GLP-1s in the US Signos is actively engaging with health insurance companies and employers to secure coverage for its system. 

The company anticipates a rapid increase in coverage as the interest in weight management solutions continues to grow.

How the Signos system works

Fouladgar-Mercer stated that the Signos system is compatible with GLP-1s or bariatric surgery. He added that the system can also help patients sustain weight loss after discontinuing GLP-1 use.

Small sensors worn on the upper arm, CGMs primarily track glucose levels in individuals with diabetes, according to the report. 

The data is transmitted wirelessly to the Signos app, which integrates with an AI platform. This platform uses the glucose data, along with patient-logged information such as food intake and exercise levels, to generate personalized recommendations.

Beyond aiding weight loss, the system is designed to help users comprehend their body’s reactions to particular foods and exercise routines. 

This understanding facilitates appropriate behavioral adjustments for long-term weight management.

While Signos did not disclose the exact number of current users for its glucose monitoring system, Fouladgar-Mercer stated that tens of thousands of individuals have utilised it over time. 

Following approval, Signos has expanded its CGM inventory and software capabilities to accommodate a significant increase in demand.

The post US FDA greenlights first glucose monitoring system for weight loss appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Pop Mart hits record high on Labubu-driven earnings; analysts see upside, risks loom
next post
Despite drone strike, Druzhba pipeline restores oil deliveries to Slovakia, Hungary

Related Posts

Europe bulletin: Zelensky calls for more weapons, Russia...

October 25, 2025

Nvidia stock edges higher amid semiconductor sector rally...

October 25, 2025

AMD stock climbs 7%, breaching $400B market cap...

October 25, 2025

US digest: Jeffries endorses Mamdani, Ford’s stock surge,...

October 25, 2025

Trump seeks Asia mineral deals to ramp up...

October 25, 2025

Lucy Powell elected deputy leader of the UK’s...

October 25, 2025

Disney warns YouTube TV subscribers of potential blackout...

October 24, 2025

Top catalysts for the CAC 40 index next...

October 24, 2025

European stocks open higher, buoyed by a wave...

October 24, 2025

NatWest share price forecast as its earnings jump:...

October 24, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • Europe bulletin: Zelensky calls for more weapons, Russia warns against EU sanctions

    October 25, 2025
  • Nvidia stock edges higher amid semiconductor sector rally and AI boom

    October 25, 2025
  • AMD stock climbs 7%, breaching $400B market cap amid chip sector rally

    October 25, 2025
  • US digest: Jeffries endorses Mamdani, Ford’s stock surge, US sanctions Colombian president

    October 25, 2025
  • Trump seeks Asia mineral deals to ramp up pressure on China’s Xi: report

    October 25, 2025
  • Lucy Powell elected deputy leader of the UK’s Labour Party

    October 25, 2025

Editors’ Picks

  • 1

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 2

    Pop Mart reports 188% profit surge, plans aggressive global expansion

    March 26, 2025
  • 3

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 4

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • 5

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025
  • 6

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 7

    Nvidia’s investment in SoundHound wasn’t all that significant after all

    March 1, 2025

Categories

  • Economy (3,000)
  • Editor's Pick (295)
  • Investing (185)
  • Stock (2,048)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

Kering share price: is the Gucci parent...

April 24, 2025

Europe markets open: Stoxx 600 flat, CAC...

October 7, 2025

Applied Materials decline after $710M revenue hit...

October 4, 2025